Were you looking for more information about Brentuximab Vedotin? Brintuximab is a common misspelling of brentuximab.
When other treatments have failed to work for certain types of lymphoma, a healthcare provider may recommend brentuximab vedotin (Adcetris™). This prescription chemotherapy drug is approved for use in adults who have Hodgkin's lymphoma or systemic anaplastic large cell lymphoma.
You may not be able to receive this drug if you have immune system problems, certain allergies, or if you are taking certain medications, vitamins, or supplements. Some of the commonly reported side effects of this drug include fatigue, nausea, and diarrhea.
(Click Brentuximab Vedotin to learn more about this form of chemotherapy, including how it works, dosing guidelines, and general safety precautions. You can also click any of the links in the box to the right for specific information.)